packageMotavizumab

motavizumab

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Motavizumab is a monoclonal antibody investigated for preventing serious respiratory syncytial virus infection in infants. It remains investigational and has not been approved for routine clinical use.

Summary written by glm-5.3-flash from Wikidata Q6917147 and the WHO ATC classification; not checked by a person.

name:motavizumab
ATC codes:J06BD02
DrugBank:DB06310
Wikidata:Q6917147

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown